The GLP-1 Receptor Agonist Liraglutide Attenuates Atherosclerotic Lesion Development and Potentially Enhances Plaque Stability in an ApoE-/- Mouse Model

被引：0
|
作者：
Simpson, Richard W.
Gaspari, Tracey
Welungoda, Iresha
Widdop, Robert E.
Knudsen, Lotte B.
Dear, Anthony E.
机构：
来源：
DIABETES | 2012年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1896-P
引用
收藏
页码：A486 / A486
页数：1
相关论文
共 50 条
  • [1] The GLP-1 receptor agonist liraglutide attenuates atherosclerotic lesion development and enhances plaque stability in an ApoE-/- mouse model
    Dear, A. E.
    Gaspari, T.
    Welungoda, I.
    Widdop, R. E.
    Simpson, R. W.
    DIABETOLOGIA, 2012, 55 : S321 - S321
  • [2] The GLP-1 receptor agonist liraglutide inhibits progression of vascular disease via effects on atherogenesis, plaque stability and endothelial function in an ApoE-/- mouse model
    Gaspari, Tracey
    Welungoda, Iresha
    Widdop, Robert E.
    Simpson, Richard W.
    Dear, Anthony E.
    DIABETES & VASCULAR DISEASE RESEARCH, 2013, 10 (04): : 353 - 360
  • [3] A GLP-1 receptor agonist liraglutide inhibits endothelial cell dysfunction and vascular adhesion molecule expression in an ApoE-/- mouse model
    Gaspari, Tracey
    Liu, HongBin
    Welungoda, Iresha
    Hu, Yunshan
    Widdop, Robert E.
    Knudsen, Lotte B.
    Simpson, Richard W.
    Dear, Anthony E.
    DIABETES & VASCULAR DISEASE RESEARCH, 2011, 8 (02): : 117 - 124
  • [4] A GLP-1 receptor agonist liraglutide inhibits endothelial cell dysfunction and vascular adhesion molecule expression in an ApoE-/- mouse model (vol 8, pg 117, 2011)
    Gaspari, Tracey
    Liu, HongBin
    Welungoda, Iresha
    Hu, Yunshan
    Widdop, Robert E.
    Knudsen, Lotte B.
    Simpson, Richard W.
    Dear, Anthony E.
    DIABETES & VASCULAR DISEASE RESEARCH, 2012, 9 (01): : 79 - 79
  • [5] The GLP-1 Receptor Agonist Liraglutide Improves Hepatic Inflammation and Fibrosis in a Mouse Model of NASH
    Montandon, Sophie A.
    Somm, Emmanuel
    De Vito, Claudio
    Jornayvaz, Francois R.
    DIABETES, 2019, 68
  • [6] Effects of GLP-1 receptor analogue liraglutide and DPP-4 inhibitor vildagliptin on the bone metabolism in ApoE-/- mice
    Zhang, Lizhi
    Li, Peicheng
    Tang, Zhaosheng
    Dou, Qin
    Feng, Bo
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (16)
  • [7] GLP-1 receptor agonist liraglutide has a neuroprotective effect on an aged rat model of Wolfram syndrome
    Kadri Seppa
    Maarja Toots
    Riin Reimets
    Toomas Jagomäe
    Tuuliki Koppel
    Maia Pallase
    Stine Hasselholt
    Maiken Krogsbæk Mikkelsen
    Jens Randel Nyengaard
    Eero Vasar
    Anton Terasmaa
    Mario Plaas
    Scientific Reports, 9
  • [8] GLP-1 receptor agonist liraglutide has a neuroprotective effect on an aged rat model of Wolfram syndrome
    Seppa, Kadri
    Toots, Maarja
    Reimets, Riin
    Jagomae, Toomas
    Koppel, Tuuliki
    Pallase, Maia
    Hasselholt, Stine
    Mikkelsen, Maiken Krogsbaek
    Nyengaard, Jens Randel
    Vasar, Eero
    Terasmaa, Anton
    Plaas, Mario
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [9] Effect of the GLP-1 Receptor Agonist, Liraglutide as an Adjunct to Insulin Treatment in a Rodent Model of Type 1 Diabetes
    Meek, Thomas H.
    Kumar, Monica
    Matsen, Miles E.
    Fischer, Jonathan D.
    Taborsky, Gerald J., Jr.
    Schwartz, Michael W.
    Morton, Gregory J.
    DIABETES, 2013, 62 : A733 - A733
  • [10] A Dual GLP-1/GIP Receptor Agonist Is More Effective than Liraglutide in the A53T Mouse Model of Parkinson's Disease
    Zhang, Zijuan
    Shi, Ming
    Li, Zhengmin
    Ling, Yuan
    Zhai, Luke
    Yuan, Ye
    Ma, He
    Hao, Li
    Li, Zhonghua
    Zhang, Zhenqiang
    Holscher, Christian
    PARKINSONS DISEASE, 2023, 2023
12345